BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Federal Trade Commission
Farmers Insurance
QuintilesIMS
Mallinckrodt
AstraZeneca
Cantor Fitzgerald
Merck
Fuji
Boehringer Ingelheim

Generated: January 16, 2018

DrugPatentWatch Database Preview

OXYBUTYNIN Drug Profile

« Back to Dashboard

Which patents cover Oxybutynin, and what generic alternatives are available?

Oxybutynin is a drug marketed by Barr Labs Div Teva, Apotex Inc, Mikart, Pharm Assoc, Silarx, Vintage Pharms, Wockhardt, Accord Hlthcare, Amneal Pharms, Impax Pharms, Mylan, Mylan Pharms Inc, Osmotica Pharm Us, Unique Pharm Labs, Zydus Pharms Usa Inc, Novitium Pharma, Quantum Pharmics, Teva Pharms Usa, Upsher-smith Labs, Usl Pharma, and Watson Labs. and is included in twenty-two NDAs.

The generic ingredient in OXYBUTYNIN is oxybutynin chloride. There are sixteen drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the oxybutynin chloride profile page.

US Patents and Regulatory Information for OXYBUTYNIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher-smith Labs OXYBUTYNIN CHLORIDE oxybutynin chloride TABLET;ORAL 074625-001 Jul 31, 1996 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Zydus Pharms Usa Inc OXYBUTYNIN CHLORIDE oxybutynin chloride TABLET, EXTENDED RELEASE;ORAL 202332-003 Jun 26, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Usl Pharma OXYBUTYNIN CHLORIDE oxybutynin chloride TABLET;ORAL 070746-001 Mar 10, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novitium Pharma OXYBUTYNIN CHLORIDE oxybutynin chloride TABLET;ORAL 209823-001 Oct 23, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr Labs Div Teva OXYBUTYNIN oxybutynin FILM, EXTENDED RELEASE;TRANSDERMAL 090526-001 Mar 4, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc OXYBUTYNIN CHLORIDE oxybutynin chloride TABLET, EXTENDED RELEASE;ORAL 076644-001 Nov 9, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Unique Pharm Labs OXYBUTYNIN CHLORIDE oxybutynin chloride TABLET, EXTENDED RELEASE;ORAL 206121-002 May 27, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wockhardt OXYBUTYNIN CHLORIDE oxybutynin chloride SYRUP;ORAL 074868-001 Feb 12, 1997 AA RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharm Assoc OXYBUTYNIN CHLORIDE oxybutynin chloride SYRUP;ORAL 075137-001 Dec 18, 1998 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms OXYBUTYNIN CHLORIDE oxybutynin chloride TABLET, EXTENDED RELEASE;ORAL 204010-002 Nov 23, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Colorcon
McKesson
Daiichi Sankyo
Moodys
Healthtrust
Farmers Insurance
Covington
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot